Population pharmacokinetic analysis of dexmedetomidine in children using real-world data from electronic health records and remnant specimens.

Abstract

Our objectives were to perform a population pharmacokinetic analysis of dexmedetomidine in children using remnant specimens and electronic health records (EHRs) and explore the impact of patient's characteristics and pharmacogenetics on dexmedetomidine clearance.